G. Langford

730 total citations
22 papers, 512 citations indexed

About

G. Langford is a scholar working on Genetics, Surgery and Molecular Biology. According to data from OpenAlex, G. Langford has authored 22 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 14 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in G. Langford's work include Xenotransplantation and immune response (14 papers), Animal Genetics and Reproduction (13 papers) and Virus-based gene therapy research (11 papers). G. Langford is often cited by papers focused on Xenotransplantation and immune response (14 papers), Animal Genetics and Reproduction (13 papers) and Virus-based gene therapy research (11 papers). G. Langford collaborates with scholars based in United Kingdom, United States and South Sudan. G. Langford's co-authors include Emanuele Cozzi, David J. White, Paul Waterworth, Michael Tolan, N. Yannoutsos, Richard Lancaster, John Dunning, Gilda Chavez, Andrew Richards and D J White and has published in prestigious journals such as Journal of Virology, Antimicrobial Agents and Chemotherapy and European Journal of Cancer.

In The Last Decade

G. Langford

21 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Langford United Kingdom 13 444 329 148 32 23 22 512
Gilda Chavez United Kingdom 12 772 1.7× 449 1.4× 160 1.1× 69 2.2× 19 0.8× 25 822
Atousa Aminian Australia 12 429 1.0× 270 0.8× 166 1.1× 84 2.6× 7 0.3× 19 556
Billeta Lewis United States 10 559 1.3× 292 0.9× 124 0.8× 56 1.8× 13 0.6× 20 620
Y. Ye United States 8 564 1.3× 297 0.9× 100 0.7× 45 1.4× 7 0.3× 9 601
Denis Lambrigts United States 7 408 0.9× 237 0.7× 88 0.6× 78 2.4× 5 0.2× 9 478
Ross L. Blankenship United States 9 440 1.0× 374 1.1× 290 2.0× 32 1.0× 8 0.3× 13 592
Luz M. Reyes United States 10 519 1.2× 330 1.0× 218 1.5× 45 1.4× 11 0.5× 17 615
Wiebke Baars Germany 14 352 0.8× 251 0.8× 177 1.2× 117 3.7× 7 0.3× 20 484
Susan M. Downey United States 9 450 1.0× 294 0.9× 217 1.5× 30 0.9× 5 0.2× 12 586
Jamie Busch United States 7 342 0.8× 223 0.7× 82 0.6× 19 0.6× 3 0.1× 8 413

Countries citing papers authored by G. Langford

Since Specialization
Citations

This map shows the geographic impact of G. Langford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Langford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Langford more than expected).

Fields of papers citing papers by G. Langford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Langford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Langford. The network helps show where G. Langford may publish in the future.

Co-authorship network of co-authors of G. Langford

This figure shows the co-authorship network connecting the top 25 collaborators of G. Langford. A scholar is included among the top collaborators of G. Langford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Langford. G. Langford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
White, David J. & G. Langford. (2021). Xenografts from Livestock. 229–242.
2.
Bennett, Gavin, Hannah Harrison, S. Campbell, et al.. (2016). Development of BT1718, a Bicycle Drug Conjugate® (BDC) targeting MT1-MMP for treatment of solid tumours. European Journal of Cancer. 69. S21–S21. 14 indexed citations
3.
Waxman, S. G., et al.. (2005). Fifteenth Meeting of the European Neurological Society 18–22 June 2005, Vienna, Austria. Journal of Neurology. 252(S2). ii1–ii51. 1 indexed citations
4.
Zhou, Chunyan, Elizabeth F. McInnes, Laura Copeman, et al.. (2004). PRODUCTION OF TRIPLE TRANSGENIC PIGS EXPRESSING HUMAN CD59, MCP AND DAF. Transplantation. 78. 576–576. 1 indexed citations
5.
Specke, Volker, Henk‐Jan Schuurman, Roland Plesker, et al.. (2002). Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates. Transplant Immunology. 9(2-4). 281–288. 54 indexed citations
6.
Herring, Christopher, Gwendolyn P. Quinn, Nick Parsons, et al.. (2001). Mapping Full-Length Porcine Endogenous Retroviruses in a Large White Pig. Journal of Virology. 75(24). 12252–12265. 51 indexed citations
7.
Powell, Sharon K., et al.. (2000). Antiretroviral Agents Inhibit Infection of Human Cells by Porcine Endogenous Retroviruses. Antimicrobial Agents and Chemotherapy. 44(12). 3432–3433. 35 indexed citations
8.
Waterworth, Paul, John Dunning, Michael Tolan, et al.. (1998). Life-supporting pig-to-baboon heart xenotransplantation.. PubMed. 17(12). 1201–7. 61 indexed citations
9.
Waterworth, Paul, Michael Tolan, Emanuele Cozzi, et al.. (1997). Life-supporting pig-to-baboon cardiac xenotransplantation. The Journal of Heart and Lung Transplantation. 16(1). 111. 1 indexed citations
10.
Waterworth, Paul, Emanuele Cozzi, Michael Tolan, et al.. (1997). Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy. Transplantation Proceedings. 29(1-2). 899–900. 47 indexed citations
11.
Mandel, T E, Maria Koulmanda, Emanuele Cozzi, et al.. (1997). Transplantation of normal and DAF-transgenic fetal pig pancreas into cynomolgus monkeys. Transplantation Proceedings. 29(1-2). 940–940. 32 indexed citations
12.
White, David J., Michael Schmoeckel, Emanuele Cozzi, Gilda Chavez, & G. Langford. (1997). Production par génie génétique de porcs pour la réalisation de xénogreffes cardiaques. BioDrugs. 8(Supplement 1). 33–36. 2 indexed citations
13.
Langford, G., et al.. (1996). Targeted in vivo gene transfection modulated hyperacute rejection of pig lungs perfused with human blood.. PubMed. 28(2). 763–763. 2 indexed citations
14.
White, David J., Emanuele Cozzi, G. Langford, et al.. (1995). The control of hyperacute rejection by genetic engineering of the donor species. Eye. 9(2). 185–189. 10 indexed citations
15.
Cary, N., et al.. (1995). Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts.. PubMed. 27(1). 326–7. 20 indexed citations
16.
Dj, White, Emanuele Cozzi, G. Langford, et al.. (1995). Genetic engineering of the donor species to control hyperacute xenograft rejection.. PubMed. 24. 331–40. 1 indexed citations
17.
Cozzi, Emanuele, et al.. (1995). Expression of human DAF and MCP on pig endothelial cells protects from human complement.. PubMed. 27(1). 321–3. 19 indexed citations
18.
White, David J., G. Langford, Emanuele Cozzi, & Vincent Young. (1995). Production of pigs transgenic for human DAF: A strategy for xenotransplantation. Xenotransplantation. 2(3). 213–217. 35 indexed citations
19.
Langford, G., N. Yannoutsos, Emanuele Cozzi, et al.. (1994). Production of pigs transgenic for human decay accelerating factor.. PubMed. 26(3). 1400–1. 75 indexed citations
20.
Cozzi, Emanuele, G. Langford, Andrew Richards, et al.. (1994). Expression of human decay accelerating factor in transgenic pigs.. PubMed. 26(3). 1402–3. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026